HHL Harvest Healthcare Leaders Income ETF
Harvest Healthcare Leaders Income ETF (HHL) holds large healthcare companies and pays high income from covered call options.
Last close $7.87 on Nov 10, 2026
Harvest Sector covered call Currency hedged Monthly
Official fund page on Harvest's siteIncome Durability Score
#20 of 51 sector covered call funds
Yield
9.1%
1-year return
+8.8%
Fee (MER)
0.98%
Worst drop
-25.7%
Liquidity
Very high
320.2K units a day
About $2,519,674 traded
Risk rating
Medium
Rated by Harvest
HHL top 10 holdings
As at Oct 30, 2026, as Harvest published them.
| Holding | Weight |
|---|---|
| Regeneron Pharmaceuticals, Inc. | 5.4% |
| AstraZeneca PLC | 5.1% |
| Bristol-Myers Squibb Company | 5.1% |
| Abbott Laboratories | 5.0% |
| Eli Lilly and Company | 5.0% |
| Merck & Co., Inc. | 5.0% |
| Vertex Pharmaceuticals Incorporated | 4.9% |
| Novartis AG | 4.9% |
| Danaher Corporation | 4.9% |
| AbbVie Inc. | 4.9% |
HHL distribution history
Pays monthly. Last paid $0.0600 a unit on Oct 30, 2026. $0.72 a unit in cash over the 12 months to then. What would $10,000 of HHL pay? Try the income calculator.
| Pay date | Per unit |
|---|---|
| Oct 30, 2026 | $0.0600 |
| Sep 29, 2026 | $0.0600 |
| Aug 31, 2026 | $0.0600 |
| Jul 31, 2026 | $0.0600 |
| Jun 30, 2026 | $0.0600 |
| May 29, 2026 | $0.0600 |
| Apr 30, 2026 | $0.0600 |
| Mar 31, 2026 | $0.0600 |
| Feb 27, 2026 | $0.0600 |
| Jan 30, 2026 | $0.0600 |
| Dec 31, 2025 | $0.0600 |
| Nov 28, 2025 | $0.0600 |
Loading charts and comparison…
Fund vs owning its top 10 stocks
Loading…
What drives the score
- Income 79
- Capital 73
- Risk 65
- Costs 81
- Diversification 63
Each bar is out of 100. How the score is built.
Similar funds
Data as of Nov 10, 2026. HHL is shown for information only: this is not a recommendation to buy or sell it.